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ABSTRACT 
IDENTIFYING MODIFIER GENES IN SMA MODEL MICE 
by 
Weiting Xu 
Spinal Muscular Atrophy (SMA) involves the loss of nerve cells called motor neurons in 
the spinal cord and is classified as a motor neuron disease, it affects 1 in 5000-10000 
newborns, one of the leading genetic causes of infant death in USA. Mutations in 
the SMN1, UBA1, DYNC1H1 and VAPB genes cause spinal muscular atrophy. Extra 
copies of the SMN2 gene modify the severity of spinal muscular atrophy. Mutations in 
SMN1 (Motor Neuron 1) mainly causes SMA (Autosomal recessive inheritance). 
SMN1 gene mutations lead to a shortage of the SMN protein and SMN protein forms 
SMN complex which take part in snRNP biogenesis and pre-mRNA splicing. Without 
SMN protein, motor neurons die, and nerve impulses are not passed between the brain 
and muscles. As a result, some muscles cannot perform their normal functions, leading to 
weakness and impaired movement. In this research, we used SMA model mice (LL 
samples and Sever samples) to identify de novo mutations and modifiers operating in 
SMA model mice. 
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1.1 Objective and Methods 
The objective of this study is to identify Modifier genes in SMA model mice. These tools 
include FastQC, Bowtie 2, SAMtools, PICARD, GATK and snpEff. Several features such 
as Mapping Reads, Alignment Manipulation, Variants Calling, Ti/Tv Ratio and 
Annotation are taken into consideration.  
For the Mapping Reads, a table was carried out based on the sequencing reads 
alignment to reference sequences. Mapping short reads against a reference genome is 
classically the first step of many next-generation sequencing data analyses, and it should 
be as accurate as possible[5].  The purpose of mapping is to create an alignment file also 
known as a Sequence/Alignment Map (SAM) file for each of samples. The SAM file will 
contain one line for each of the reads in your sample denoting the reference sequence 
(genes, contigs, or gene regions) to which it maps, the position in the reference sequence, 
and a Phred-scaled quality score of the mapping. The SAM files can be used for samples 
to extract gene expression information[1]. 
For Variants Calling, PICARD tools and GATK are taken into consideration. 
There are 8 VCF files have been generated to identify sequence variants. 
SnpEff is used in Annotation, it is an genetic variant annotation and effect 
prediction toolbox. It annotates and predicts the effects of variants on genes (such as 
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amino acid changes). The inputs are predicted variants (SNPs, insertions, deletions and 
MNPs). The input file is obtained as a result of a sequencing experiment, and it is in 
variant call format (VCF). SnpEff analyzes the input variants. It annotates the variants 
and calculates the effects they produce on known genes.  
 
1.2 Background Information 
Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder caused by 
the loss of function of motor neurons[3]. The loss of motor neurons leads to weakness 
and wasting (atrophy) of muscles used for activities such as crawling, walking, sitting up, 
and controlling head movement. In severe cases of spinal muscular atrophy, the muscles 
used for breathing and swallowing are affected. 
Four main types of spinal muscular atrophy affect children before the age of 1. 
Type I spinal muscular atrophy is a severe form of the disorder that is evident at birth or 
within the first few months of life. Affected infants are developmentally delayed, most 
are unable to support their head or sit unassisted and have difficulty breathing and 
swallowing that may lead to choking or gagging and are unable to sit without support. 
Type II spinal muscular atrophy is characterized by muscle weakness that 
develops in children between ages 6 and 12 months. Children with type II can sit without 
support, although they cannot stand or walk unaided[1]. 
Type III spinal muscular atrophy has milder features that typically develop 
between early childhood and adolescence. Individuals with type III spinal muscular 
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atrophy can stand and walk unaided, but walking and climbing stairs may become 
increasingly difficult. Many affected individuals will require wheelchair assistance later 
in life[7]. 
The signs and symptoms of type IV spinal muscular atrophy often occur after age 
30[8]. Affected individuals usually experience mild to moderate muscle weakness, tremor, 
twitching, or mild breathing problems. Typically, only muscles close to the center of the 
body (proximal muscles), such as the upper arms and legs, are affected in type IV spinal 
muscular atrophy[1][6]. 
Mutations in the SMN1, UBA1, DYNC1H1 and VAPB genes cause spinal muscular 
atrophy. Extra copies of the SMN2 gene modify the severity of spinal muscular atrophy. 
Mutations in the SMN1 (survival motor neuron 1) gene cause spinal muscular 
atrophy types I, II, III, and IV. SMN1 gene mutations lead to a shortage of the SMN 
protein. Without SMN protein, motor neurons die, and nerve impulses are not passed 
between the brain and muscles. As a result, some muscles cannot perform their normal 
functions, leading to weakness and impaired movement. 
SMN1 is the primary SMA-related gene. Approximately 95% - 98% of individuals 
with a clinical diagnosis of SMA are homozygous for a deletion or gene 
conversion of SMN1, typically determined by lack of exon 7 in both copies of SMN1. 
Approximately 2% - 5% of individuals with a clinical diagnosis of SMA are compound 
heterozygotes for deletion of at least SMN1 exon 7 and an intragenic 
inactivating mutation of SMN1 that is detectable by sequence analysis[4]. Figure 2.1 
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shows how SMN1 mutation causes SMA. 
 
Figure 2.1 The molecular basis of proximal spinal muscular atrophy depicting the two 
major genes involved in the disease, SMN1, and the modifier, SMN2. 
 
Source: Monani UR. (2005). Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor 








2.1 SMA Model Mice 
In this paper experiment, there are eight samples which are divided into two families in 
SMA model mice. We used LL samples (Long Live samples) and sever samples which 
came from same parents pair for exome sequencing. Our LL and typical SMA mice are a 
mix of the FVB/N and C57BL/6 strains of mice. FVB/N mice offer a system suitable for 
most transgenic experiments and subsequent genetic analyses[10]. C57BL/6 is a 
common inbred strain of laboratory mouse.It is the most widely used "genetic 
background" for genetically modified mice for use as models of human disease. Figure 






Figure 2.2 Appearance results within different time range. 
 
Source: From our cooperation Columbia University Biology Lab  
 
Figure 2.3 shows Kaplan-Meier survival curve analysis and it indicates a highly 
significant effect of modifiers in an F1 intercross between C57Bl/6 and FVB/N compared 







Figure 2.3 Kaplan-Meier survival curve analysis. 
 
Source: From our cooperation Columbia University Biology Lab 
 
Table 2.1 shows the probability of LL mutants in each generation. The detailed 
information about data in this experiment is showed in Table 2.2. Family #1: UM01, 
UM02 and UM03 are LL samples, UM05 and UM07 are sever samples. Family #2: 
UM11 and UM12 are LL samples, and UM13 is sever sample. 
 
Table 2.1 Probability of LL Mutants in Each Generation 
Generation  Probability of LL Mutants 
Per All Mutants  
Number of Samples 
F1xF1 4% 1 out of 25 
F2xF2 13.3% 6 out of 45 
F3xF3 27.9% 19 out of 68 
If modifiers works as autosomal recessive manner, 1 modifier become 




1. In F1xF1 generation, the probability of LL is 4%. Therefore, we estimated that at 
least 2 modifiers (most likely 3 modifiers) are existing is LL mutants. 
 
2. In F2xF2 and F3xF3 generations, probability of LL was increased due to the 
biased selection of breeding pairs (the breeding pair which produce LL mice were 
more frequently used for breeding.)  
 
3. In F3xF3 generation, probability of LL is above 25%. This is indicating that 2 
modifiers (if 3 mods exist) might be already homozygously fixed in breeding pair. 
 
Table 2.2 Description of the SMA Model Mice 
 LL Samples Sever Samples 
Family #1 UM01, UM02, UM03 UM05, UM07 







ALIGNMENT AND COUNTS 
 
3.1 Mapping Reads 
Bowtie 2 is an ultrafast and memory-efficient tool for aligning sequencing reads to long 
reference sequences.  It is particularly good at aligning reads of about 50 up to 100s or 
1,000s of characters, and particularly good at aligning to relatively long genomes. Bowtie 
2 is often the first step in pipelines for comparative genomics, including for variation 
calling, ChIP-seq, RNA-seq, BS-seq. Multiple processors can be used simultaneously to 
achieve greater alignment speed.  
We use Bowtie 2 for aligning our mouse data to mm9 fasta reference data and 
select reads that have a mapping quality of 20 or better (DP > 20) and then count the 
amount of those mapped reads and save it in the Table 3.1 Amount of mapped reads. Next 
step we use SAMtools to count the amount of mapped reads in target region which 
named S0276129_Regions bed file download from SureDesign website and we save the 
count number in the Table 3.1 Amount of mapped reads in target region. SAMtools 
provide various utilities for manipulating alignments in the SAM format, including 






Table 3.1 Summary of the Mapping Reads 
ID Amount of mapped reads Amount of mapped reads 
in target region 
UM01 48055975 36786262 
UM02 45410389 30674883 
UM03 59372714 47783279 
UM05 42657431 34684432 
UM07 40806247 30727583 
UM11 41675811 31039464 
UM12 62132734 48285532 
UM13 40781358 31228352 
 
3.2 Evaluation by Ti/Tv Ratio 
Ti/Tv ratio is also known as Transition-Transversion ratio. This is a ratio of the number of 
transition to transversion substitutions that appear to have occurred since two sequences 
separated from a common ancestor. It is also the average rate of transition versus 
transversion substitutions in a dataset. What’s more, Ti/Tv ratio is a value, estimated by 
reference to a tree that describes the average rate of transition to transversion 
substitutions during the evolutionary period covered by the tree. Estimation of the ti/tv 
rate bias is important not only to our understanding of the patterns of DNA sequence 
evolution, but also to reliable estimation of sequence distance and phylogeny 
reconstruction[9].  
The Figure 3.2 is an illustration. AG, CT pairs are defined as transitions, while 
other pairs are considered as transversions. The Table 3.2 we calculate variants Ti/Tv 
Ratio in target region (S0276129_Regions bed file). Expected human Ti/Tv ratio for 
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whole-genome is 2.1 and for whole-exome is 3.0, FP SNPs should have a Ti/Tv of 0.5. 
Note that these expectations are only for individual sequencing data. It may not be held 
for pooled sequencing data. There is no expected Ti/Tv ratio for mouse now so we just 




Figure 3.2 Definition of transitions and transversions. 
 







Table 3.2 Ti/Tv Ratio 









































4.1 Alignment Manipulation and Variants Calling   
After we finish the alignment mapping, the next step is to do the alignment manipulation 
and variants calling. We utilize several PICARD tools to summarize the alignments and 
use GATK to analyze data. We have 8 VCF files which contains specific variants after 
these steps. The Table 4.1 shows the description of each column in VCF file.  
      Picard comprises Java-based command-line utilities that manipulate SAM files, 
and a Java API (HTSJDK) for creating new programs that read and write SAM files. Both 
SAM text format and SAM binary (BAM) format are supported. We choose several 
PICARD tools: 
1. CollectAlignmentSummaryMetrics, it reads a SAM or BAM file and writes a file 
containing summary alignment metrics. 
 
2. MarkDuplicates, it examines aligned records in the supplied SAM or BAM file to 
locate duplicate molecules. All records are then written to the output file with the 
duplicate records flagged.   
 
3. AddOrReplaceReadGroups, it replaces all read groups in the INPUT file with a 
new read group and assigns all reads to this read group in the OUTPUT. Note that 
this step is required by the latest GATK, which no longer supports SAM files 
without read groups. 
 
4. BuildBamIndex, generates a BAM index (.bai) file using PICARD. 
 
After the PICARD we do the Variants Detection by GATK. The Genome Analysis 
Toolkit (GATK) is a software package developed at the Broad Institute to analyze 
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next-generation sequencing data. The toolkit offers a wide variety of tools, with a primary 
focus on variant discovery and genotyping as well as strong emphasis on data quality 
assurance. It consists of the following steps: 
1. Call variants by UnifiedGenotyper, we use the GATK Unified Genotyper to detect 
variants, which is based on a Bayesian genotype likelihood model. The variant 
calls are stored in VCF (Variant Call Format). 
 
2. Select variants from a VCF source, a VCF containing many samples and/or 
variants will need to be subset in order to facilitate certain analyses (e.g. 
comparing and contrasting cases vs. controls). SelectVariants can be used for this 
purpose. Given a single VCF file, one or more samples can be extracted from the 
file (based on a complete sample name or a pattern match). Variants can be further 
selected by specifying criteria for inclusion. In this experiment we use 
SelectVariants to select variants which has “DP > 20” (depth of coverage greater 
than 20x). 
 
3. We use intersect function to select variants in target region (S0276129_Regions 
bed file). The variant calls are stored in VCF. 
 
Table 4.1 Description of Each Column in Output VCF File  
VCF Column Description 
1st chromosome number 
2nd snp location 
3rd ID: unique identifier 
4th reference base 
5th sample base 
6th phred-scaled quality score 
7th filter 







We use those variants that have DP>20 (depth of coverage greater than 20x) and 
intersected reads in target region (S0276129_Regions bed file) to do annotate. We chose 
snpEff tool.  
SnpEff is a variant annotation and effect prediction tool. It annotates and predicts 
the effects of variants on genes (such as amino acid changes). The inputs are predicted 
variants (SNPs, insertions, deletions and MNPs). The input file is usually obtained as a 
result of a sequencing experiment, and it is usually in variant call format (VCF). SnpEff 
analyzes the input variants. It annotates the variants and calculates the effects they 
produce on known genes (e.g. amino acid changes). SnpEff updates the header of the 
VCF file to reflect additional fields. It also adds the command line options used to 
annotate the file as well as SnpEff's version, so we can keep track of what exactly was 
done. 
4.3 Filtering 
We use previous variants VCF file to do filtering to find those variants that will impact 
protein functions and follow inheritance model (recessive model). The most recent 
analysis which our cooperative team members carried out using a panel of 1500 SNPs at 
the Jackson Labs suggests that there is a major modifier of the SMA phenotype on 
chromosome 9 of the mouse genome.  Accordingly, we have been scouring the genes in 
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this region for variants between FVB/N and C57Bl6 for further clues.  One caveat of this 
strategy is that the modifier arise de novo in our colony of mice.  If this is the case, we 
will miss it by simply comparing sequences in the publicly available databases.  In 
essence then, the idea would be to compare sequence variants (initially only protein 
coding) on chromosome 9 in our long-lived mice using C57Bl6 as the reference sequence 
on the one hand and FVB/N as the reference sequence on the other.  Any de 
novo alterations in our mice would then become apparent and can be combined with our 
SNP analysis data to further home in on potential individual modifiers. Then, the idea 
consists of the following steps: 
1. Identify chromosome 9 variants in LL samples, i.e., UM01, UM02, UM03, UM11, 
UM12. Limit these to variants that either alter the coding sequence of the protein 
or the splice sites of the gene. So we select chr 9 first from variants get from 
Annotation in LL samples and then we select missense_variant and 
splice_region_variant. 
2. Determine which of the above variants are common to all LL samples. 
3. Identify chromosome 9 variants in all typical samples, i.e., UM05, UM07, UM13. 
Limit these to variants that either alter the coding sequence of the protein or the 
splice sites of the gene. So we select chr 9 first from variants get from Annotation 
in typical samples and then we select missense_variant and splice_region_variant. 
4. Determine which of the variants identified in step 3 are common to all typical 
samples. 
5. Identify which of the variants in step 3 are present only in the typical samples and 
not in the LL samples. Further identify which of the variants from step 1 are 
present in all or a majority of the LL samples but absent in the typical samples. 
Here we use R packages to do the intersection and set difference. The Table 4.3 
shows variants present only in the typical samples and not in the LL samples; The 





6. Using variants identified in step 1, determine which of the variants in the LL mice 
derive from the FVB/N strain of mice.   
7. Remove variants identified in step 1 that derive from the FVB/N strain. This will 
leave variants that are most likely de novo mutations, i.e., those that arose in in 
our colony of mice. The Table 4.5 shows variants that are most likely de novo 
mutations.  
8. Determine which of the possible de novo mutations identified in step 7 are 
common to all LL samples.  Identify which, if any, of these are also present in 
the typical samples. The Table 4.6 shows possible de novo mutations identified in 















Our LL and typical SMA mice are a mix of the FVB/N and C57Bl/6 strains of mice. 
Based on our mapping studies and on the incidence of the LL mice, we expect a total of 
2-3 modifiers at least one of which is recessively inherited.   
As expected, from Table 4.3 we found 55 variants, 18 variants in UM05, 5 
variants in UM07 and 32 variants in UM13. From Table 4.4 we found 335 variants, 5 
variants in UM01, 224 variants in UM02, 7 variants in UM03, 5 variants in UM11 and 94 
variants in UM12. From Table 4.5 we found 506 variants, 70 variants in UM01, 243 
variants in UM02, 20 variants in UM03, 62 variants in UM11 and 111 variants in UM12. 
And from Table 4.6 we only found 2 variants left, these two are possible de novo 













POSSIBLE de novo MUTATIONS AND MODIFIERS OPERATING IN SMA 
MODEL MICE 
Possible de novo mutations and modifiers operating in SMA model mice are provided in 
the following Tables.  
Table A.1 UM07 Variants Present Only in the Typical Samples and not in the LL 
Samples 
UM07 
#CHROM POS Gene_Name REF ALT 
chr9 49213127 Drd2 C A 
chr9 55062707 Fbxo22 C G 
chr9 78179006 Gsta2 A C 
chr9 87134697 Cep162 G A 










Table A.2 UM05 Variants Present Only in the Typical Samples and not in the LL 
Samples 
UM05 
#CHROM POS Gene_Name REF ALT 
chr9 38238446 Olfr901 C G 
chr9 56108186 Peak1 C A 
chr9 56108188 Peak1 C T 
chr9 86489810 Me1 A G 
chr9 92164821 Plscr1 G C 
chr9 95582036 Pcolce2 G A 
chr9 95593325 Pcolce2 T C 
chr9 95765989 Atr C G 
chr9 96233950 Atp1b3 C T 
chr9 96234031 Atp1b3 T C 
chr9 96234041 Atp1b3 C T 
chr9 96587156 Zbtb38 G A 
chr9 96587405 Zbtb38 C T 
chr9 97355119 Clstn2 A C 
chr9 97355144 Clstn2 T G 
chr9 99231120 Esyt3 C T 
chr9 100386717 Il20rb A T 









Table A.3 UM13 Variants Present Only in the Typical Samples and not in the LL 
Samples 
UM13 
#CHROM POS Gene_Name REF ALT 
chr9 19180243 Olfr847 G C 
chr9 19180247 Olfr847 A T 
chr9 19180248 Olfr847 G T 
chr9 20065163 Olfr872 C G 
chr9 23203898 Bmper T A 
chr9 37892652 Olfr887 T G 
chr9 37892653 Olfr887 A G 
chr9 37892654 Olfr887 A T 
chr9 37892655 Olfr887 C T 
chr9 39647108 Olfr971 C T 
chr9 39647114 Olfr971 C T 
chr9 39681067 Olfr972 T A 
chr9 39681072 Olfr972 C G 
chr9 39681073 Olfr972 T G 
chr9 44317448 Bcl9l A T 
chr9 45510729 Dscaml1 G T 
chr9 45510731 Dscaml1 A T 
chr9 48823237 Usp28 G T 
chr9 54863461 Chrna3 G T 
chr9 55285397 AI118078 C T 
chr9 59513732 Pkm C T 
chr9 59513733 Pkm G C 
chr9 65642524 Zfp609 C T 
chr9 89862738 Rasgrf1 C A 
chr9 92161439 Plscr1 G A 
chr9 95609223 Trpc1 A T 
chr9 100397792 Nck1 C A 
chr9 103183362 1300017J02Rik C A 
chr9 103183365 1300017J02Rik C A 
chr9 106760944 Vprbp C A 
chr9 108009008 Bsn C T 
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chr9 108012524 Bsn A C 
 
Table A.4 UM01 Variants Present in all LL Samples but Absent in the Typical Samples 
UM01 
#CHROM POS Gene_Name REF ALT 
chr9 32064570 Arhgap32 C G 
chr9 79991493 Senp6 A G 
chr9 87141166 Cep162 T C 
chr9 90120887 Tbc1d2b T C 
chr9 122834341 Zfp105 A C 
 
Table A.5 UM03 Variants Present in all LL Samples but Absent in the Typical Samples 
UM03 
#CHROM POS Gene_Name REF ALT 
chr9 20867155 Zglp1 C A 
chr9 56108190 Peak1 C T 
chr9 61804006 Paqr5 C A 
chr9 75195821 Bcl2l10 G A 
chr9 75238180 Mapk6 G T 
chr9 75238181 Mapk6 G C 






Table A.6 UM02 Variants Present in all LL Samples but Absent in the Typical Samples 
UM02 
#CHROM POS Gene_Name REF ALT 
chr9 4330888 Kbtbd3 G A 
chr9 5321472 Casp4 G T 
chr9 5321474 Casp4 C T 
chr9 6265244 Ddi1 C A 
chr9 6265245 Ddi1 A C 
chr9 7005535 Dync2h1 C G 
chr9 7005537 Dync2h1 A T 
chr9 7142292 Dync2h1 C A 
chr9 7451731 Mmp3 T A 
chr9 7854589 Birc3 C T 
chr9 8099848 AK129341 T A 
chr9 8652980 Trpc6 G A 
chr9 8652983 Trpc6 C A 
chr9 9673889 Cntn5 C T 
chr9 14604060 Mre11a G T 
chr9 15122153 Cep295 T A 
chr9 15127320 Cep295 G A 
chr9 15136690 Cep295 G T 
chr9 15136691 Cep295 G A 
chr9 15136693 Cep295 T A 
chr9 15136694 Cep295 G A 
chr9 15140072 Cep295 T A 
chr9 15140073 Cep295 C G 
chr9 15140075 Cep295 T G 
chr9 15719744 Fat3 G T 
chr9 15719745 Fat3 G A 
chr9 15808505 Fat3 G A 
chr9 18105499 Chordc1 G A 
chr9 18183070 Naalad2 C A 
chr9 18249145 Mbd3l2 G T 
chr9 18289497 Mbd3l1 C T 
chr9 18620250 Olfr828 C A 
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chr9 18749821 Olfr832 C T 
chr9 19371266 Olfr854 C G 
chr9 19612851 Olfr859 C A 
chr9 19612854 Olfr859 T A 
chr9 19612858 Olfr859 T A 
chr9 19724728 Olfr77 C A 
chr9 19725116 Olfr77 G T 
chr9 19905202 Olfr868 G A 
chr9 20065081 Olfr872 T A 
chr9 20576761 Col5a3 G A 
chr9 20813042 Mrpl4 C G 
chr9 20813043 Mrpl4 C T 
chr9 20830828 Icam1 G T 
chr9 24279840 Dpy19l1 G T 
chr9 31137256 Prdm10 G T 
chr9 31217945 Nfrkb T A 
chr9 31217947 Nfrkb C T 
chr9 32056163 Arhgap32 A T 
chr9 32064402 Arhgap32 G A 
chr9 32203916 Kcnj1 T A 
chr9 35019942 Srpr C A 
chr9 37044551 Slc37a2 C G 
chr9 37833933 Olfr883 C A 
chr9 38017436 Olfr893 C T 
chr9 38017438 Olfr893 G A 
chr9 38137762 Olfr25 C T 
chr9 38256498 Olfr902 C A 
chr9 38256501 Olfr902 G A 
chr9 38256966 Olfr902 G T 
chr9 38257198 Olfr902 G A 
chr9 38324354 Olfr908 T A 
chr9 38401852 Olfr913 G C 
chr9 38401853 Olfr913 G A 
chr9 38402124 Olfr913 T A 
chr9 38402127 Olfr913 T A 
chr9 38480786 Olfr918 A T 
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chr9 38505759 Olfr919 C A 
chr9 38505932 Olfr919 G T 
chr9 38685070 Olfr926 T A 
chr9 38867838 Olfr937 A T 
chr9 38951907 Olfr27 C A 
chr9 39025727 Olfr944 C A 
chr9 39202209 Olfr951 T A 
chr9 39202210 Olfr951 C A 
chr9 39202212 Olfr951 G A 
chr9 39358175 Olfr958 A T 
chr9 39544463 Olfr150 C T 
chr9 39544592 Olfr150 G T 
chr9 39544593 Olfr150 C G 
chr9 39544595 Olfr150 G A 
chr9 39558019 Olfr967 G A 
chr9 39558021 Olfr967 T A 
chr9 39558031 Olfr967 C A 
chr9 39681268 Olfr972 T A 
chr9 39681269 Olfr972 G T 
chr9 40613062 Hspa8 A C 
chr9 43854739 Thy1 C T 
chr9 44432691 Ddx6 G T 
chr9 44629233 Kmt2a C A 
chr9 45680035 Rnf214 C T 
chr9 46100258 Bud13 G A 
chr9 48128691 Nxpe2 C A 
chr9 48128744 Nxpe2 T C 
chr9 48134429 Nxpe2 C G 
chr9 48134430 Nxpe2 A G 
chr9 49086802 Gm4894 C A 
chr9 49086804 Gm4894 T A 
chr9 49210350 Drd2 C T 
chr9 49210353 Drd2 C T 
chr9 50608230 Alg9 A T 
chr9 50608232 Alg9 C A 
chr9 51647028 Arhgap20 G A 
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chr9 53308901 Atm C A 
chr9 53335437 Atm G A 
chr9 53371037 Npat T A 
chr9 54264543 Dmxl2 T A 
chr9 54275846 Dmxl2 C A 
chr9 56105408 Peak1 C A 
chr9 56107575 Peak1 C A 
chr9 56107577 Peak1 C A 
chr9 56107579 Peak1 T G 
chr9 56107580 Peak1 T A 
chr9 56740315 Cspg4 A T 
chr9 57101972 1700017B05Rik C T 
chr9 58488505 Nptn A C 
chr9 59627997 Myo9a C T 
chr9 59628006 Myo9a A T 
chr9 59680060 Myo9a C A 
chr9 63372766 Iqch T A 
chr9 64982405 Igdcc4 G T 
chr9 65323649 Spg21 T A 
chr9 66102402 Dapk2 A G 
chr9 66281948 Herc1 C A 
chr9 66318169 Herc1 G T 
chr9 66803713 Lactb T A 
chr9 69263617 Ice2 C T 
chr9 69263620 Ice2 T A 
chr9 69844903 Bnip2 A T 
chr9 70277410 Rnf111 T A 
chr9 70277411 Rnf111 C G 
chr9 70291401 Rnf111 G A 
chr9 70434520 Sltm G T 
chr9 72178796 Zfp280d C G 
chr9 72178798 Zfp280d C A 
chr9 72464565 Rfx7 A T 
chr9 72465438 Rfx7 C T 
chr9 72587340 Nedd4 G T 
chr9 72587341 Nedd4 T A 
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chr9 72793276 Pygo1 G C 
chr9 72886431 Pigb T A 
chr9 73780131 Unc13c T A 
chr9 74066394 Wdr72 C T 
chr9 74737323 Onecut1 G T 
chr9 74737325 Onecut1 A T 
chr9 77639876 Gclc G A 
chr9 77639878 Gclc C A 
chr9 77823610 Elovl5 G A 
chr9 78308647 Mto1 T G 
chr9 78308649 Mto1 G A 
chr9 78508747 Cd109 G C 
chr9 78528716 Cd109 G A 
chr9 79541172 Col12a1 T A 
chr9 79551638 Col12a1 C G 
chr9 79551641 Col12a1 C T 
chr9 80129398 Myo6 G A 
chr9 80193399 Impg1 T A 
chr9 85604075 Ibtk G A 
chr9 85622103 Ibtk A T 
chr9 85622104 Ibtk C A 
chr9 85622105 Ibtk C A 
chr9 85637159 Ibtk C A 
chr9 85637299 Ibtk C T 
chr9 86406201 Dopey1 G C 
chr9 87088515 Cep162 C T 
chr9 87143279 Cep162 C G 
chr9 87143317 Cep162 A T 
chr9 87143320 Cep162 G T 
chr9 88293202 Snx14 G T 
chr9 88293204 Snx14 G C 
chr9 88371744 Syncrip C A 
chr9 88371746 Syncrip C G 
chr9 89491399 AF529169 G T 
chr9 89497377 AF529169 C A 
chr9 89839643 Rasgrf1 A C 
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chr9 89839644 Rasgrf1 C A 
chr9 92185938 Plscr2 T G 
chr9 92490170 Plod2 T C 
chr9 95396352 U2surp G T 
chr9 95878281 Xrn1 A T 
chr9 95882343 Xrn1 G T 
chr9 95939143 Xrn1 C T 
chr9 95939144 Xrn1 A G 
chr9 96240725 Atp1b3 C T 
chr9 96588607 Zbtb38 G A 
chr9 98481612 Copb2 T A 
chr9 98481614 Copb2 C A 
chr9 98804165 7420426K07Rik C A 
chr9 98973990 Pik3cb T C 
chr9 99479865 Dbr1 T C 
chr9 99479868 Dbr1 G T 
chr9 99617481 Cldn18 A T 
chr9 100781294 Stag1 C A 
chr9 101113913 Ppp2r3a C A 
chr9 101831624 Ephb1 A T 
chr9 103230742 Topbp1 G C 
chr9 103907843 Nphp3 T A 
chr9 105842055 Col6a5 C A 
chr9 106197534 Poc1a T A 
chr9 106387469 Rrp9 G A 
chr9 106760608 Vprbp C A 
chr9 106760610 Vprbp G A 
chr9 106881075 Dock3 G T 
chr9 107667818 Rbm5 T A 
chr9 108307741 Ccdc36 T A 
chr9 108465610 Impdh2 G A 
chr9 108482164 P4htm T C 
chr9 108698628 Ip6k2 T A 
chr9 108698629 Ip6k2 T A 
chr9 108872553 Col7a1 G T 
chr9 108992003 Ccdc51 G A 
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chr9 109794260 Cdc25a T A 
chr9 110420128 Kif9 C A 
chr9 110451909 Setd2 C A 
chr9 110495073 Setd2 C T 
chr9 111293250 Trank1 G T 
chr9 111474884 Stac C T 
chr9 115155165 Stt3b T A 
chr9 122834341 Zfp105 A C 
chr9 122857133 1110059G10Rik G A 
chr9 122857136 1110059G10Rik C A 
chr9 123479114 Sacm1l G T 
chr9 123943822 Ccr3 C A 
 
Table A.7 UM11 Variants Present in all LL Samples but Absent in the Typical Samples 
UM11 
#CHROM POS Gene_Name REF ALT 
chr9 32064570 Arhgap32 C G 
chr9 79991493 Senp6 A G 
chr9 87141166 Cep162 T C 
chr9 90120887 Tbc1d2b T C 










Table A.8 UM12 Variants Present in all LL Samples but Absent in the Typical Samples 
UM12 
#CHROM POS Gene_Name REF ALT 
chr9 3458760 Cwf19l2 G A 
chr9 4472124 Gria4 G A 
chr9 4472125 Gria4 C A 
chr9 6265403 Ddi1 C A 
chr9 7447622 Mmp3 T A 
chr9 7447625 Mmp3 A C 
chr9 14888710 Hephl1 A G 
chr9 18679785 Olfr830 G C 
chr9 18680357 Olfr830 C A 
chr9 18680364 Olfr830 A T 
chr9 18839764 Olfr835 T A 
chr9 19905445 Olfr868 G A 
chr9 20090340 Olfr39 C T 
chr9 37663042 Olfr877 C A 
chr9 37705250 Olfr145 A T 
chr9 37705253 Olfr145 A G 
chr9 37705255 Olfr145 A T 
chr9 37727015 Olfr878 T A 
chr9 37892427 Olfr887 G A 
chr9 37892918 Olfr887 A T 
chr9 37892919 Olfr887 C T 
chr9 37916766 Olfr888 G C 
chr9 37916769 Olfr888 G A 
chr9 37916770 Olfr888 C A 
chr9 37916773 Olfr888 G T 
chr9 37916774 Olfr888 C G 
chr9 38017396 Olfr893 T A 
chr9 38061670 Olfr143 A G 
chr9 38061709 Olfr143 G A 
chr9 38137186 Olfr25 G A 
chr9 38137187 Olfr25 C T 
chr9 38156679 Olfr898 A C 
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chr9 38210776 Olfr147 C A 
chr9 38210782 Olfr147 C A 
chr9 38271775 Olfr904 G A 
chr9 38402127 Olfr913 T A 
chr9 38623387 Olfr922 C A 
chr9 38655923 Olfr924 A G 
chr9 38655924 Olfr924 C A 
chr9 38802432 Olfr935 T G 
chr9 38867955 Olfr937 C G 
chr9 38867956 Olfr937 C A 
chr9 38867982 Olfr937 T C 
chr9 38991986 Olfr943 C A 
chr9 39065420 Olfr945 G A 
chr9 39269838 Olfr954 G A 
chr9 39318982 Olfr957 C T 
chr9 39319039 Olfr957 T G 
chr9 39319044 Olfr957 A T 
chr9 39431016 Olfr960 T G 
chr9 39454395 Olfr961 T A 
chr9 39454397 Olfr961 T A 
chr9 39454398 Olfr961 T G 
chr9 39454399 Olfr961 T A 
chr9 39454400 Olfr961 T C 
chr9 39603161 Olfr969 C A 
chr9 39627436 Olfr970 C A 
chr9 39627956 Olfr970 A C 
chr9 39628040 Olfr970 A T 
chr9 40610828 Hspa8 A T 
chr9 40612763 Hspa8 G T 
chr9 45719163 Pcsk7 T G 
chr9 54264543 Dmxl2 T A 
chr9 54731831 Ireb2 T C 
chr9 54754461 Ireb2 C A 
chr9 55062811 Fbxo22 A T 
chr9 56818116 Snupn T C 
chr9 57872976 Cyp11a1 G A 
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chr9 58725960 Neo1 G T 
chr9 66349065 Herc1 C G 
chr9 70258022 Ccnb2 G A 
chr9 72462964 Rfx7 T A 
chr9 72462966 Rfx7 C A 
chr9 73546927 Unc13c C A 
chr9 75241169 Mapk6 T G 
chr9 78176355 Omt2b T C 
chr9 79528174 Col12a1 C A 
chr9 79528175 Col12a1 C T 
chr9 80110160 Myo6 G T 
chr9 85604075 Ibtk G A 
chr9 85604076 Ibtk C A 
chr9 85604077 Ibtk C A 
chr9 85604078 Ibtk T A 
chr9 85637086 Ibtk C T 
chr9 87122023 Cep162 G T 
chr9 95364782 U2surp C T 
chr9 1.03E+08 Topbp1 G T 
chr9 1.03E+08 Topbp1 G T 
chr9 1.04E+08 Dnajc13 C T 
chr9 1.06E+08 Col6a4 C T 
chr9 1.1E+08 Setd2 A C 
chr9 1.14E+08 Ubp1 A T 
chr9 1.19E+08 Itga9 C A 







Table B.9 UM01 Variants Are Most Likely de novo Mutations  
UM01 
#CHROM POS Gene_Name REF ALT 
chr9 32256985 Arhgap32 C G 
chr9 55209076 Fbxo22 G A 
chr9 55209101 Fbxo22 G T 
chr9 55209382 Fbxo22 G A 
chr9 55221070 Fbxo22 A C 
chr9 55221151 Fbxo22 G T 
chr9 75388680 Mapk6 T A 
chr9 78053997 Gcm1 C T 
chr9 78377563 Ooep C T 
chr9 79647575 Col12a1 A G 
chr9 80093551 Senp6 G C 
chr9 80116600 Senp6 A C 
chr9 80130844 Senp6 G C 
chr9 80143686 Senp6 A G 
chr9 80316176 Impg1 G T 
chr9 80394203 Impg1 T A 
chr9 80465254 Impg1 C A 
chr9 80465281 Impg1 C A 
chr9 85719091 Ibtk A G 
chr9 85732671 Ibtk C A 
chr9 85844637 Tpbg C T 
chr9 85844843 Tpbg C A 
chr9 86502989 Dopey1 G A 
chr9 86562676 Pgm3 C G 
chr9 86586988 Me1 C T 
chr9 86815426 Snap91 A G 
chr9 87040451 Cyb5r4 A G 
chr9 87057232 Cyb5r4 G A 
chr9 87058957 Cyb5r4 G A 
chr9 87217153 Cep162 T C 
chr9 87220446 Cep162 T C 
chr9 87225720 Cep162 C T 
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chr9 87225946 Cep162 T G 
chr9 87227270 Cep162 T C 
chr9 87231408 Cep162 C T 
chr9 87246331 Cep162 T C 
chr9 87248431 Cep162 A G 
chr9 88364661 Nt5e T C 
chr9 89915497 Rasgrf1 G A 
chr9 90064250 Ctsh A T 
chr9 90193461 Adamts7 G T 
chr9 90193821 Adamts7 C T 
chr9 90226049 Tbc1d2b T C 
chr9 90227473 Tbc1d2b T C 
chr9 104018241 Nphp3 A G 
chr9 104024628 Nphp3 A C 
chr9 104024641 Nphp3 C T 
chr9 104024658 Nphp3 A G 
chr9 104029997 Nphp3 A G 
chr9 104031987 Nphp3 G A 
chr9 104033409 Nphp3 G A 
chr9 104075894 Acad11 A C 
chr9 104076435 Acad11 A G 
chr9 118572989 Golga4 A C 
chr9 122857512 Zfp445 A G 
chr9 122861850 Zfp445 C G 
chr9 122861902 Zfp445 A G 
chr9 122888831 Zkscan7 T C 
chr9 123151098 Clec3b G C 
chr9 123151102 Clec3b T C 
chr9 123977439 Ccr1l1 T A 
chr9 123977442 Ccr1l1 T C 
chr9 124028846 Ccr3 A G 
chr9 124106378 Ccr2 G A 
chr9 124124393 Ccr5 G T 
chr9 124124686 Ccr5 C G 
chr9 124124828 Ccr5 C T 
chr9 124124840 Ccr5 T C 
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chr9 124124915 Ccr5 C T 
chr9 124125315 Ccr5 G T 
 
Table A.10 UM02 Variants Are Most Likely de novo Mutations 
UM02 
#CHROM POS Gene_Name REF ALT 
chr9 4330888 Kbtbd3 G A 
chr9 5321472 Casp4 G T 
chr9 5321474 Casp4 C T 
chr9 6265244 Ddi1 C A 
chr9 6265245 Ddi1 A C 
chr9 7005535 Dync2h1 C G 
chr9 7005537 Dync2h1 A T 
chr9 7142292 Dync2h1 C A 
chr9 7451731 Mmp3 T A 
chr9 7854589 Birc3 C T 
chr9 8099848 AK129341 T A 
chr9 8652980 Trpc6 G A 
chr9 8652983 Trpc6 C A 
chr9 9673889 Cntn5 C T 
chr9 14799616 Mre11a G T 
chr9 15317709 Cep295 T A 
chr9 15322876 Cep295 G A 
chr9 15332246 Cep295 G T 
chr9 15332247 Cep295 G A 
chr9 15332249 Cep295 T A 
chr9 15332250 Cep295 G A 
chr9 15335628 Cep295 T A 
chr9 15335629 Cep295 C G 
chr9 15335631 Cep295 T G 
chr9 15915300 Fat3 G T 
chr9 15915301 Fat3 G A 
chr9 16004061 Fat3 G A 
chr9 18301055 Chordc1 G A 
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chr9 18378626 Naalad2 C A 
chr9 18444701 Mbd3l2 G T 
chr9 18485053 Mbd3l1 C T 
chr9 18815806 Olfr828 C A 
chr9 18945377 Olfr832 C T 
chr9 19566822 Olfr854 C G 
chr9 19808407 Olfr859 C A 
chr9 19808410 Olfr859 T A 
chr9 19808414 Olfr859 T A 
chr9 19920284 Olfr77 C A 
chr9 19920672 Olfr77 G T 
chr9 20100758 Olfr868 G A 
chr9 20260637 Olfr872 T A 
chr9 20772317 Col5a3 G A 
chr9 21008598 Mrpl4 C G 
chr9 21008599 Mrpl4 C T 
chr9 21026384 Icam1 G T 
chr9 24475396 Dpy19l1 G T 
chr9 31329671 Prdm10 G T 
chr9 31410360 Nfrkb T A 
chr9 31410362 Nfrkb C T 
chr9 32248578 Arhgap32 A T 
chr9 32256817 Arhgap32 G A 
chr9 32396331 Kcnj1 T A 
chr9 35212357 Srpr C A 
chr9 37236966 Slc37a2 C G 
chr9 38026348 Olfr883 C A 
chr9 38209851 Olfr893 C T 
chr9 38209853 Olfr893 G A 
chr9 38330177 Olfr25 C T 
chr9 38448913 Olfr902 C A 
chr9 38448916 Olfr902 G T 
chr9 38449381 Olfr902 G A 
chr9 38449613 Olfr902 T A 
chr9 38516769 Olfr908 T A 
chr9 38594267 Olfr913 G C 
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chr9 38594268 Olfr913 G A 
chr9 38594539 Olfr913 T A 
chr9 38594542 Olfr913 T A 
chr9 38673201 Olfr918 A T 
chr9 38698174 Olfr919 C A 
chr9 38698347 Olfr919 G T 
chr9 38877485 Olfr926 T A 
chr9 39060253 Olfr937 A T 
chr9 39144322 Olfr27 C A 
chr9 39218142 Olfr944 C A 
chr9 39394624 Olfr951 T A 
chr9 39394625 Olfr951 C A 
chr9 39394627 Olfr951 G A 
chr9 39550590 Olfr958 A T 
chr9 39736878 Olfr150 C T 
chr9 39737007 Olfr150 G T 
chr9 39737008 Olfr150 C G 
chr9 39737010 Olfr150 G A 
chr9 39750434 Olfr967 G A 
chr9 39750436 Olfr967 T A 
chr9 39750446 Olfr967 C A 
chr9 39873683 Olfr972 T A 
chr9 39873684 Olfr972 G T 
chr9 40804979 Hspa8 A C 
chr9 44046656 Thy1 C T 
chr9 44624608 Ddx6 G T 
chr9 44821150 Kmt2a C A 
chr9 45871952 Rnf214 C T 
chr9 46292175 Bud13 G A 
chr9 48320608 Nxpe2 C A 
chr9 48320661 Nxpe2 T C 
chr9 48326346 Nxpe2 C G 
chr9 48326347 Nxpe2 A G 
chr9 49278697 Gm4894 C A 
chr9 49278699 Gm4894 T A 
chr9 49402245 Drd2 C T 
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chr9 49402248 Drd2 C T 
chr9 50800125 Alg9 A T 
chr9 50800127 Alg9 C A 
chr9 51838923 Arhgap20 G A 
chr9 53500796 Atm C A 
chr9 53527332 Atm G A 
chr9 53562932 Npat T A 
chr9 54416736 Dmxl2 T A 
chr9 54428039 Dmxl2 C A 
chr9 55209076 Fbxo22 G A 
chr9 55209101 Fbxo22 G T 
chr9 55209382 Fbxo22 G A 
chr9 55221070 Fbxo22 A C 
chr9 55221151 Fbxo22 G T 
chr9 56257601 Peak1 C A 
chr9 56259768 Peak1 C A 
chr9 56259770 Peak1 C A 
chr9 56259772 Peak1 T G 
chr9 56259773 Peak1 T A 
chr9 56892508 Cspg4 A T 
chr9 57254165 1700017B05Rik C T 
chr9 58640698 Nptn A C 
chr9 59780190 Myo9a C T 
chr9 59780199 Myo9a A T 
chr9 59832253 Myo9a C A 
chr9 63524959 Iqch T A 
chr9 65134598 Igdcc4 G T 
chr9 65475842 Spg21 T A 
chr9 66254595 Dapk2 A G 
chr9 66434141 Herc1 C A 
chr9 66470362 Herc1 G T 
chr9 66955906 Lactb T A 
chr9 69415810 Ice2 C T 
chr9 69415813 Ice2 T A 
chr9 69997096 Bnip2 A T 
chr9 70429603 Rnf111 T A 
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chr9 70429604 Rnf111 C G 
chr9 70443594 Rnf111 G A 
chr9 70586713 Sltm G T 
chr9 72330989 Zfp280d C G 
chr9 72330991 Zfp280d C A 
chr9 72616758 Rfx7 A T 
chr9 72617631 Rfx7 C T 
chr9 72739533 Nedd4 G T 
chr9 72739534 Nedd4 T A 
chr9 72945469 Pygo1 G C 
chr9 73038624 Pigb T A 
chr9 73932324 Unc13c T A 
chr9 74218587 Wdr72 C T 
chr9 74889516 Onecut1 G T 
chr9 74889518 Onecut1 A T 
chr9 75388680 Mapk6 T A 
chr9 77792069 Gclc G A 
chr9 77792071 Gclc C A 
chr9 77975803 Elovl5 G A 
chr9 78460840 Mto1 T G 
chr9 78460842 Mto1 G A 
chr9 78660940 Cd109 G C 
chr9 78680909 Cd109 G A 
chr9 79693365 Col12a1 T A 
chr9 79703831 Col12a1 C G 
chr9 79703834 Col12a1 C T 
chr9 80281591 Myo6 G A 
chr9 80345592 Impg1 T A 
chr9 85710468 Ibtk G A 
chr9 85728496 Ibtk A T 
chr9 85728497 Ibtk C A 
chr9 85728498 Ibtk C A 
chr9 85743552 Ibtk C A 
chr9 85743692 Ibtk C T 
chr9 86512594 Dopey1 G C 
chr9 87193680 Cep162 C T 
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chr9 87248444 Cep162 C G 
chr9 87248482 Cep162 A T 
chr9 87248485 Cep162 G T 
chr9 88398364 Snx14 G T 
chr9 88398366 Snx14 G C 
chr9 88476906 Syncrip C A 
chr9 88476908 Syncrip C G 
chr9 89596561 AF529169 G T 
chr9 89602539 AF529169 C A 
chr9 89944805 Rasgrf1 A C 
chr9 89944806 Rasgrf1 C A 
chr9 92291100 Plscr2 T G 
chr9 92595332 Plod2 T C 
chr9 95495933 U2surp G T 
chr9 95977862 Xrn1 A T 
chr9 95981924 Xrn1 G T 
chr9 96038724 Xrn1 C T 
chr9 96038725 Xrn1 A G 
chr9 96340306 Atp1b3 C T 
chr9 96688188 Zbtb38 G A 
chr9 98581193 Copb2 T A 
chr9 98581195 Copb2 C A 
chr9 98903746 7420426K07Rik C A 
chr9 99073571 Pik3cb T C 
chr9 99579446 Dbr1 T C 
chr9 99579449 Dbr1 G T 
chr9 99717062 Cldn18 A T 
chr9 100880875 Stag1 C A 
chr9 101211583 Ppp2r3a C A 
chr9 101929294 Ephb1 A T 
chr9 103328412 Topbp1 G C 
chr9 104005513 Nphp3 T A 
chr9 105939724 Col6a5 C A 
chr9 106295203 Poc1a T A 
chr9 106485138 Rrp9 G A 
chr9 106858277 Vprbp C A 
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chr9 106858279 Vprbp G A 
chr9 106978744 Dock3 G T 
chr9 107765487 Rbm5 T A 
chr9 108405410 Ccdc36 T A 
chr9 108563279 Impdh2 G A 
chr9 108579833 P4htm T C 
chr9 108796297 Ip6k2 T A 
chr9 108796298 Ip6k2 T A 
chr9 108970508 Col7a1 G T 
chr9 109089489 Ccdc51 G A 
chr9 109891756 Cdc25a T A 
chr9 110517624 Kif9 C A 
chr9 110549405 Setd2 C A 
chr9 110592569 Setd2 C T 
chr9 111390746 Trank1 G T 
chr9 111572380 Stac C T 
chr9 115246047 Stt3b T A 
chr9 122861850 Zfp445 C G 
chr9 122861902 Zfp445 A G 
chr9 122888831 Zkscan7 T C 
chr9 122948015 1110059G10Rik G A 
chr9 122948018 1110059G10Rik C A 
chr9 123151098 Clec3b G C 
chr9 123151102 Clec3b T C 
chr9 123569996 Sacm1l G T 
chr9 124028800 Ccr3 G A 
chr9 124028846 Ccr3 A G 
chr9 124029090 Ccr3 C A 
chr9 124106378 Ccr2 G A 
chr9 124124393 Ccr5 G T 
chr9 124124686 Ccr5 C G 
chr9 124124828 Ccr5 C T 
chr9 124124840 Ccr5 T C 
chr9 124124915 Ccr5 C T 




Table A.11 UM03 Variants Are Most Likely de novo Mutations 
UM03 
#CHROM POS Gene_Name REF ALT 
chr9 55209076 Fbxo22 G A 
chr9 55209101 Fbxo22 G T 
chr9 55209382 Fbxo22 G A 
chr9 55221070 Fbxo22 A C 
chr9 55221151 Fbxo22 G T 
chr9 75388680 Mapk6 T A 
chr9 122861850 Zfp445 C G 
chr9 122861902 Zfp445 A G 
chr9 122888831 Zkscan7 T C 
chr9 123151098 Clec3b G C 
chr9 123151102 Clec3b T C 
chr9 124028800 Ccr3 G A 
chr9 124028846 Ccr3 A G 
chr9 124106378 Ccr2 G A 
chr9 124124393 Ccr5 G T 
chr9 124124686 Ccr5 C G 
chr9 124124828 Ccr5 C T 
chr9 124124840 Ccr5 T C 
chr9 124124915 Ccr5 C T 
chr9 124125315 Ccr5 G T 
 
Table A.12 UM11 Variants Are Most Likely de novo Mutations 
UM11 
#CHROM POS Gene_Name REF ALT 
chr9 4384050 Msantd4 G A 
chr9 13620666 Maml2 C G 
chr9 16375123 Fat3 T G 
chr9 19783342 Olfr58 G T 
chr9 19783344 Olfr58 C G 
chr9 19783346 Olfr58 T A 
43 
 
chr9 19783347 Olfr58 G A 
chr9 22073489 Ecsit C G 
chr9 37804144 Olfr876 C A 
chr9 37897523 Olfr145 G A 
chr9 37993020 Olfr881 A G 
chr9 38025884 Olfr883 C A 
chr9 38047249 Olfr884 T A 
chr9 38330231 Olfr25 C G 
chr9 38368163 Olfr899 G A 
chr9 38368165 Olfr899 G C 
chr9 38516769 Olfr908 T G 
chr9 38698217 Olfr919 G T 
chr9 38698223 Olfr919 G T 
chr9 38698224 Olfr919 G C 
chr9 38698225 Olfr919 A C 
chr9 38698231 Olfr919 A C 
chr9 38698235 Olfr919 C T 
chr9 38734706 Vwa5a T A 
chr9 38877245 Olfr926 C T 
chr9 39217779 Olfr944 T A 
chr9 39669141 Olfr963 T C 
chr9 39750446 Olfr967 C A 
chr9 39750547 Olfr967 C A 
chr9 39750587 Olfr967 C A 
chr9 39839757 Olfr971 G T 
chr9 45176520 Tmprss4 C A 
chr9 49507015 Ncam1 T A 
chr9 50754536 Cryab T A 
chr9 50754540 Cryab T A 
chr9 50870073 Ppp2r1b T A 
chr9 55209076 Fbxo22 G A 
chr9 55209101 Fbxo22 G T 
chr9 55221070 Fbxo22 A C 
chr9 58025169 Cyp11a1 G A 
chr9 66133477 Fam96a A T 
chr9 66133479 Fam96a A C 
44 
 
chr9 75347972 Bcl2l10 G A 
chr9 78157903 Ick A T 
chr9 78478834 Eef1a1 C T 
chr9 78480516 Eef1a1 C A 
chr9 79700278 Col12a1 G T 
chr9 104176665 Dnajc13 A T 
chr9 109192770 Fbxw13 G T 
chr9 109494760 Fbxw19 C G 
chr9 109494761 Fbxw19 T C 
chr9 109722093 Fbxw26 G C 
chr9 113915213 Clasp2 G T 
chr9 114430321 Glb1 T G 
chr9 114430325 Glb1 T G 
chr9 116109988 Tgfbr2 T A 
chr9 118115340 Cmc1 C A 
chr9 119609842 Scn10a A C 
chr9 122856819 Zfp445 A T 
chr9 123183722 Cdcp1 C G 
chr9 123183723 Cdcp1 T G 
chr9 124125017 Ccr5 T G 
 
Table A.13 UM12 Variants Are Most Likely de novo Mutations 
UM12 
#CHROM POS Gene_Name REF ALT 
chr9 3458760 Cwf19l2 G A 
chr9 4472124 Gria4 G A 
chr9 4472125 Gria4 C A 
chr9 6265403 Ddi1 C A 
chr9 7447622 Mmp3 T A 
chr9 7447625 Mmp3 A C 
chr9 15084266 Hephl1 A G 
chr9 18875341 Olfr830 G C 
chr9 18875913 Olfr830 C A 
chr9 18875920 Olfr830 A T 
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chr9 19035320 Olfr835 T A 
chr9 20101001 Olfr868 G A 
chr9 20285896 Olfr39 C T 
chr9 37855457 Olfr877 C A 
chr9 37897665 Olfr145 A T 
chr9 37897668 Olfr145 A G 
chr9 37897670 Olfr145 A T 
chr9 37919430 Olfr878 T A 
chr9 38084842 Olfr887 G A 
chr9 38085333 Olfr887 A T 
chr9 38085334 Olfr887 C T 
chr9 38109181 Olfr888 G C 
chr9 38109184 Olfr888 G A 
chr9 38109185 Olfr888 C A 
chr9 38109188 Olfr888 G T 
chr9 38109189 Olfr888 C G 
chr9 38209811 Olfr893 T A 
chr9 38254085 Olfr143 A G 
chr9 38254124 Olfr143 G A 
chr9 38329601 Olfr25 G A 
chr9 38329602 Olfr25 C T 
chr9 38349094 Olfr898 A C 
chr9 38403191 Olfr147 C A 
chr9 38403197 Olfr147 C A 
chr9 38464190 Olfr904 G A 
chr9 38594542 Olfr913 T A 
chr9 38815802 Olfr922 C A 
chr9 38848338 Olfr924 A G 
chr9 38848339 Olfr924 C A 
chr9 38994847 Olfr935 T G 
chr9 39060370 Olfr937 C G 
chr9 39060371 Olfr937 C A 
chr9 39060397 Olfr937 T C 
chr9 39184401 Olfr943 C A 
chr9 39217779 Olfr944 T A 
chr9 39257835 Olfr945 G A 
46 
 
chr9 39462253 Olfr954 G A 
chr9 39511397 Olfr957 C T 
chr9 39511454 Olfr957 T G 
chr9 39511459 Olfr957 A T 
chr9 39623431 Olfr960 T G 
chr9 39646810 Olfr961 T A 
chr9 39646812 Olfr961 T A 
chr9 39646813 Olfr961 T G 
chr9 39646814 Olfr961 T A 
chr9 39646815 Olfr961 T C 
chr9 39795576 Olfr969 C A 
chr9 39819851 Olfr970 C A 
chr9 39820371 Olfr970 A C 
chr9 39820455 Olfr970 A T 
chr9 40802745 Hspa8 A T 
chr9 40804680 Hspa8 G T 
chr9 45911080 Pcsk7 T G 
chr9 54416736 Dmxl2 T A 
chr9 54884024 Ireb2 T C 
chr9 54906654 Ireb2 C A 
chr9 55209076 Fbxo22 G A 
chr9 55209360 Fbxo22 C T 
chr9 55209382 Fbxo22 G A 
chr9 55215004 Fbxo22 A T 
chr9 55221070 Fbxo22 A C 
chr9 55221151 Fbxo22 G T 
chr9 56970309 Snupn T C 
chr9 58025169 Cyp11a1 G A 
chr9 58878153 Neo1 G T 
chr9 66501258 Herc1 C G 
chr9 70410215 Ccnb2 G A 
chr9 72615157 Rfx7 T A 
chr9 72615159 Rfx7 C A 
chr9 73699120 Unc13c C A 
chr9 75388680 Mapk6 T A 
chr9 75393362 Mapk6 T G 
47 
 
chr9 78328548 Omt2b T C 
chr9 79680367 Col12a1 C A 
chr9 79680368 Col12a1 C T 
chr9 80262353 Myo6 G T 
chr9 85710468 Ibtk G A 
chr9 85710469 Ibtk C A 
chr9 85710470 Ibtk C A 
chr9 85710471 Ibtk T A 
chr9 85743479 Ibtk C T 
chr9 87227188 Cep162 G T 
chr9 95464363 U2surp C T 
chr9 103320639 Topbp1 G T 
chr9 103338288 Topbp1 G T 
chr9 104018241 Nphp3 A G 
chr9 104024628 Nphp3 A C 
chr9 104024641 Nphp3 C T 
chr9 104024658 Nphp3 A G 
chr9 104029997 Nphp3 A G 
chr9 104031987 Nphp3 G A 
chr9 104075894 Acad11 A C 
chr9 104203437 Dnajc13 C T 
chr9 106026522 Col6a4 C T 
chr9 110549496 Setd2 A C 
chr9 113958852 Ubp1 A T 
chr9 118689396 Itga9 C A 
chr9 122857512 Zfp445 A G 
chr9 122861850 Zfp445 C G 
chr9 122861902 Zfp445 A G 







Table A.14 Possible de novo Mutations Identified in Step 7 Are Common to All LL 
Samples and Are Also Present in the Typical Samples 
 
#CHROM POS Gene_Name REF ALT 
chr9 55209076 Fbxo22 G A 









































1. De Wit P, Pespeni MH, Ladner JT, Barshis DJ, Seneca F, Jaris H, Overgaard 
Therkildsen N, Morikawa M and Palumbi SR. (2012). The simple fool's guide to 
population genomics via RNA-Seq: an introduction to high-throughput 
sequencing data analysis.  Molecular Ecology Resources, 12, 1058-1067. 
 
2. Noah’s Ark Children’s Services Resource Unit. (2009). Infantile Spinal Muscular 
Atrophy 
 
3. Sheets, Kayla Mandel, M.S. (2014). Spinal muscular atrophy. Salem Press 
Encyclopedia of Health 
 
4. Thomas W Prior, Barry S Russman. (2013). GeneReviews: Spinal Muscular Atrophy 
 
5. Sophie Schbath, Véronique Martin, Matthias Zytnicki, Julien Fayolle, Valentin Loux, 
and Jean-François Gibrat. (2012). Mapping Reads on a Genomic Sequence: An 
Algorithmic Overview and a Practical Comparative Analysis. J Comput Biol, 
19(6), 796–813. 
 
6. Spinal muscular atrophy. (2013). The Genetics Home Reference  
 
7. AHM Lai, ES Tan, HY Law, CS Yoon, ISL Ng. (2005). SMN1 Deletions Among 
Singaporean Patients With Spinal Muscular Atrophy. Annals Academy of 
Medicine. 34 
 
8. Zerres K, Rudnik-Schoneborn S, Forkert R, Wirth B. (1995). Genetic basis of 
adult-onset spinal muscular atrophy. Lancet. 346, 1162. 
 
9. Yang Z, Yoder AD. (1999). Estimation of the transition/transversion rate bias and 
species sampling. J Mol Evol. 48(3), 274-83. 
 
10. M Taketo, A C Schroeder, L E Mobraaten, K B Gunning, G Hanten, R R Fox, T H 
Roderick, C L Stewart, F Lilly, C T Hansen. (1991). FVB/N: an inbred mouse 
strain preferable for transgenic analyses. Proc Natl Acad Sci U S A. 88(6), 
2065-2069. 
 
11. Hahnen E, Schonling J, Rudnik-Schoneborn S, Raschke H, Zerres K, Wirth B. (1997). 
Missense mutations in exon 6 of the survival motor neuron gene in patients with 
spinal muscular atrophy (SMA). Hum Mol Genet. 6, 821–5. 
